Galapagos « Terug naar discussie overzicht

Overname van....Gilead....?

3 Posts
diederique
0
kan zomaar gebeuren...

.....The latest idea? That the Dublin drugmaker may target Gilead, whose $107 billion market cap is quite a ways off
of the heights it reached last year.

www.fiercepharma.com/pharma/allergan-...
diederique
0
Will Gilead Make a Good Fit for Allergan?

Allergen’s surprise interest emerged without any earlier indications of interest in companies focused on NASH or liver diseases. Given the backdrop of recent acquisitions, the market is abuzz with rumors about Gilead being the next potential target for Allergan.

www.investopedia.com/news/will-gilead...
diederique
0
Allergan joins a growing field of companies intent on conquering NASH, which include Gilead Sciences Inc. GILD, -0.10% , Bristol-Myers Squibb Co. BMY, +0.23% , Intercept Pharmaceuticals Inc. ICPT, -2.42% , Galmed Pharmaecuticals Ltd. GLMD, -1.64% , Astra-Zeneca Plc AZN, -0.88% and Novartis AG NVS, -0.53% , among others, according to BioMedTracker.

www.marketwatch.com/story/allergan-is...
3 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 5 feb 2025 15:28
Koers 21,920
Verschil -0,100 (-0,45%)
Hoog 22,000
Laag 21,800
Volume 28.897
Volume gemiddeld 111.945
Volume gisteren 94.575

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront